Britain says Omicron accounts for 40% of London infections | Inquirer News

Britain says Omicron accounts for 40% of London infections

/ 04:01 PM December 13, 2021

Britain says Omicron accounts for 40% of London infections

FILE PHOTO: People queue outside a coronavirus disease (COVID-19) vaccination center at St Thomas’ Hospital as the pandemic continues, in London, Britain, December 12, 2021. REUTERS/May James

LONDON Britain said Monday that the Omicron variant of coronavirus was spreading at a “phenomenal rate” and accounted for about 40% of all infections in London so people should get an additional dose of the vaccine because double-jabbed people are vulnerable.

Since the first cases of the Omicron variant were detected on Nov. 27 in the United Kingdom, Prime Minister Boris Johnson has imposed tougher restrictions and told the nation on Sunday that a “tidal wave” of Omicron was about to hit.

Article continues after this advertisement

Britain says that unless action is taken there could be a million people infected with Omicron, which scientists say can still infect people who are double-vaccinated, by the end of the month.

FEATURED STORIES

“What we now know about Omicron is that… it’s spreading at a phenomenal rate, something that we’ve never seen before, it’s doubling every two to three days in infections,” Health Secretary Sajid Javid told Sky News.

“That means we’re facing a tidal wave of infection, we’re once again in a race between the vaccine and the virus.”

Article continues after this advertisement

The pound fell 0.4% to $1.3225, while it was broadly steady against the euro at 85.29 pence.

Article continues after this advertisement

Johnson, who is grappling with a rebellion in his party over measures to curb the Omicron spread and an outcry over alleged Downing Street parties during last year’s lockdowns, said people should rush to get booster vaccines to protect “our freedoms and our way of life.”

Article continues after this advertisement

The novel coronavirus, which was first detected in China in late 2019, has killed 5.3 million people, wiped out trillions of dollars in economic output, and turned normal life upside down for people across the world.

Data released on Friday showed that vaccine efficacy against symptomatic infection was substantially reduced against Omicron with just two doses, but a third dose boosted protection up to over 70%.

Article continues after this advertisement

Though Javid said there had been no deaths yet confirmed in England and just 10 people were hospitalized in England with the variant, he said Omicron was probably behind around 40% of infections in London.

He said that while symptoms of the variant might be milder, its swift spread meant that unless the government acted then the health service could be overwhelmed.

“Even when a virus is mild, a small percentage of people from a very large number still can equal a high number of hospitalizations,” Javid said.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

“Two doses are not enough, but three doses still provide excellent protection against symptomatic infection,” he said.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: Britain, COVID-19, Health

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.